share_log

丽珠集团(000513.SZ):上半年净利润11.71亿元 同比增长3.21%

Livzon Pharmaceutical Group Inc. (000513.SZ): net income for the first half of the year was 1.171 billion yuan, a year-on-year increase of 3.21%.

Gelonghui Finance ·  Aug 22 06:07

Livzon Pharmaceutical Group Inc. (000513.SZ) announced its semi-annual report for 2024, with operating income of 6.282 billion yuan, a decrease of 6.09% compared to the same period last year; net income attributable to shareholders of listed companies was 1.171 billion yuan, an increase of 3.21% compared to the same period last year; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 1.155 billion yuan, an increase of 5.65% compared to the same period last year; basic earnings per share was 1.27 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment